On September 23, 2026, IM Cannabis Corp. entered into securities purchase agreements to issue and sell 655,000 common shares at $2.00 per share in a registered direct offering. The transaction generated approximately $1,310,000 in gross proceeds before expenses, with closing expected on September 24, 2026. Proceeds are designated for working capital and general corporate purposes, including evaluating potential business opportunities. The company operates in the medical cannabis industry.
